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Abstract
Background: This study compared TB diagnostic tools and estimated levels of misdiagnosis in a resource-limited setting.
Furthermore, we estimated the diagnostic utility of three-TB-associated predictors in an algorithm with and without Direct
Ziehl-Neelsen (DZM).
Materials and Methods: Data was obtained from a cross-sectional study in 2011 conducted at Mubende regional referral
hospital in Uganda. An individual was included if they presented with a two weeks persistent cough and or lymphadenitis/
abscess. 344 samples were analyzed on DZM in Mubende and compared to duplicates analyzed on direct fluorescent
microscopy (DFM), growth on solid and liquid media at Makerere University. Clinical variables from a questionnaire and DZM
were used to predict TB status in multivariable logistic and Cox proportional hazard models, while optimization and
visualization was done with receiver operating characteristics curve and algorithm-charts in Stata, R and Lucid-Charts
respectively.
Results: DZM had a sensitivity and specificity of 36.4% (95% CI = 24.9–49.1) and 97.1%(95% CI = 94.4–98.7) compared to
DFM which had a sensitivity and specificity of 80.3%(95% CI = 68.7–89.1) and 97.1%(95% CI = 94.4–98.7) respectively. DZM
false negative results were associated with patient’s HIV status, tobacco smoking and extra-pulmonary tuberculosis. One of
the false negative cases was infected with multi drug resistant TB (MDR). The three-predictor screening algorithm with and
without DZM classified 50% and 33% of the true cases respectively, while the adjusted algorithm with DZM classified 78% of
the true cases.
Conclusion: The study supports the concern that using DZM alone risks missing majority of TB cases, in this case we found
nearly 60%, of who one was an MDR case. Although adopting DFM would reduce this proportion to 19%, the use of a three-
predictor screening algorithm together with DZM was almost as good as DFM alone. It’s utility is whoever subject to HIV
screening all TB suspects.
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Introduction
Tuberculosis (TB) remains a disease of major global public
health concern in spite of the efforts to combat it. The WHO
estimates that about three million people who developed TB in
2012 were missed by the national notification systems [1]. Experts
in the field emphasize that a successful international and national
TB control program ought to be hinged on accurate diagnosis of
active TB cases [2,3]. Although case detection in developing
countries likes Uganda has increased over the years, some resource
limited settings like Mubende have continued to register poor case
detection levels [4]. There are various TB diagnostic tools
available [5], however, there is a universal recognition of
limitations with the commonly used tools.
Direct smear microscopy (DZM) which uses Ziehl-Neelsen as
the acid-fast dye is the most commonly used of the WHO
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recommended diagnostic tool for tuberculosis in low and middle-
income countries [3,6]. This is mainly because it is cheap, easy to
operate and rapid [6]. However, the test has a low sensitivity, with
a detection limit of between 5,000–10,000 bacilli/ml of sample [7–
9]. For patients with a low bacillary load, as seen in HIV patients
and infants, true positive cases can easily be missed [10–12]. It has
been suggested that the low sensitivity of DZM could partly be due
to the fact that facilities in high incidence areas where the test is
used as a sole diagnostic tool are usually resource limited, and thus
leading to high workload on personnel [10–12]. Over the years
there have been better diagnostic techniques, however their
adaptation to resource poor settings remains a challenge. For
example the low sensitivity of DZM can be improved by sputum
concentration and/or use of direct fluorescence microscopy
(DFM) which uses auramines as the acid-fast dye [13,14]. This
test has an added advantage of requiring only one or two sputum
specimens rather than three to reach an acceptable level of
performance, which in effect reduces the diagnostic time [13,14].
Several studies documenting the diagnostic gain of DFM have
recommended its implementation [5,13]. Unfortunately, most of
these studies have been performed at validation stages and only a
few have documented its performance in routine practice. It is
therefore important to document the performance of DFM
compared to DZM in a resource limited clinical setting so as to
inform policy makers on proper implementation of TB diagnostics
[14].
Culture of mycobacteria on solid media has been considered the
gold standard for tuberculosis diagnosis. The minimum detection
limit of 10 mycobacteria/ml significantly surpasses the minimum
detection limit given by DZM [15]. Unfortunately, the growth of
TB bacilli requires a protracted period of 4–8 weeks, delaying
appropriate treatment in the absence of a confirmed diagnosis.
The Mycobacteria growth indicator tubes (MGIT) on the other
hand is a fully automated, non-invasive system for recovery of
mycobacteria in liquid culture medium but has a draw-back of
being expensive [16]. Previous laboratory studies have shown a
higher and faster recovery of mycobacteria from sputum
specimens than culture on solid medium [17,18] but the crucial
diagnostic value is better harnessed if deployed in large diagnostic
facilities. This is because of the infrastructure, high skill and
maintenance requirements all of which are scarce in rural settings.
It is noteworthy that, under and over diagnosis contributes to
further spread of the disease and wastage of scarce resources on
inappropriate treatment respectively. It is therefore crucial to find
a cost effective sequences and/or combination of these tools to
strike a balance between these two attributes. The use of an
algorithm/screening-sequence that combines both the clinical
picture and diagnostic tools could guide physicians in establishing
this balance. There have been multitudes of conflicting evaluation
reports on the efficiency of the 2007 WHO diagnostic algorithms
for TB diagnosis in different settings [8,19–21].
Therefore it is critical to continuously refine diagnostic protocols
in resource-limited settings. This will not only improve case
detection, but also identify areas within the diagnostic chain that
are most likely to lead to over and under diagnosis (misdiagnosis).
Therefore the aim of this study was to compare diagnostic tools
used at the Mubende regional referral hospital with an extra set of
tools used during a research study period in order to:
a) Assess the performance of direct Z&N microscopy (DZM) in
detecting TB cases from clinical specimens.
b) Estimate the utility of three TB-associated predictors in an
algorithm with and without DZM.
To achieve these, results from direct smear microscopic
examination of sputum, lymph node and abscess aspirates at
Mubende regional referral hospital were compared to results from
duplicates analysed using fluorescent microscopy (DZM), culture
on LJ media and MGIT at the Mycobacteriology Laboratory,
Department of Medical Microbiology, Makerere University
[22,23]. Only TB cases caused by bacteria in the Mycobacterium
tuberculosis Complex (MTC) were considered in this analysis
[22,23]. It should also be noted that DZM is the only diagnostic
tool used at Mubende regional referral hospital. Although the
hospital has radiology facilities, these are mainly used for
orthopaedic purposes.
Materials and Methods
Ethical considerations
Full ethical clearance (ref: HS 879) was obtained from the
Uganda National Council for Science and Technology (UNCST).
Prior to this study, healthcare authorities and the research team
were briefed about the ethical issues. Due to logistical and facility
setup, oral consent was obtained from participating patients
(documented on the information sheets), something that was in
line with the research ethical mandate given by UNCST.
Furthermore, data were anonymised before analyses as stipulated
by the UNCST guidelines of research involving human as research
participants (2.2/b-e/2007).
Study site
Mubende district is located in the central region of Uganda,
inhabited by approximately 750,000 people of whom an estimated
64% live below the poverty line in population dense urban and
peri-urban areas [24]. Piot’s model on TB treatment and health
seeking suggests that only 20% of examined individuals seeking
care at a health facility will be diagnosed [25]. In this regard,
according to socio- anthropological studies on mycobacterial
infections in the Uganda [26], it is estimated that only 35% of the
Ugandan population, especially in the Uganda cattle corridor
(where Mubende districts is located), seeks health care from
allopathic practitioners [26]. This status quo would suggests that
only a fraction of TB cases make it to hospitals which probably
explains the low TB case detection level of 37% in Mubende
district [4].
Study design and population
This study was part of a wider study of the molecular
epidemiology of TB in Mubende district of Uganda conducted
by the same authors and described elsewhere [22,23]. Briefly, data
was obtained from a cross sectional study conducted between
February and July 2011. The participating patients had to have
presented with cervical lymphadenitis/abscesses and/or a cough
that had persisted for at least two weeks at Mubende regional
referral hospital. The national tuberculosis program (NTP) is only
run at this referral hospital in the Mubende district and all
persistent ailments are treated here. This implies that the majority
of residents in this district who met the study’s criteria would most
likely be treated at this facility.
Sample collection
Sputum and/or lymph node aspirates were collected using
standard procedures as described by Muwonge et al. [23]. One
appropriate sample was collected from patients that had either a
cough or lymphadenitis/abscess, or both from patients that had
both clinical presentations. A total of 344 samples from 344
patients were taken in duplicates. One of the duplicates was
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delivered to the diagnostic laboratory within Mubende regional
referral hospital for DZM and the other was delivered to the bio-
safety level 3 (BSL3) Mycobacteriology Laboratory, Department of
Medical Microbiology, Makerere University. Here direct fluores-
cent microscopy (DFM), culture and drug resistance tests (DST)
were carried out (Figure 1). A questionnaire was also administered
to each patient to retrieve information about the patients’ socio-
economic welfare, as an addition to the clinical information (Table
S1).
Diagnostic Tools
Direct Ziehl-Neelsen smear microscopy (DZM). At
Mubende regional referral hospital, direct smears from each
sample were examined with the Ziehl-Neelsen (ZN) method
(Figure 1). A sample smear prepared on slide, air-dried and heat
fixed. It was flooded with 1% carbol fuchsin and heated (steaming
NOT boiling) for five minutes. This was then washed with water
and decolorized using 3% acid-alcohol followed by a brief wash
with water. It was then stained with 0.3% methylene blue for 30–
60 seconds and then washed with water and air-dried. This slide
was then visualized under a light microscope (Olympus CX31)
using a 103 magnification. A positive sample was defined as one
that showed acid-fast rods in a 300 fields of the slide as
recommended by WHO [27–29].
Direct fluorescent smear microscopy (DFM). Smears
were made from the duplicate samples and stained for fluorescent
microscopy according to standard method [5,28]. The light source
used was a Light Emitting Diode (LED) (Fraen Corporation Srl,
Via delle Querce, Trivolzio(Pv) Italy). Thereafter the bacillary load
was established. Bacillary load is a measure of culture forming
units as seen with the aid of staining dye and is used to quantify the
number of bacilli in a sample [27–29]. If a sample contains 10–99
Figure 1. Sampling and sample analysis flow chat.
doi:10.1371/journal.pone.0100720.g001
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acid fast bacilli (AFB) per 100 fields it is categorized as +1, and if it
contains 1–10 AFB/field in 50 fields this is categorized as 2+, while
if a sample contains .10 AFB/field in 20 fields it is categorized as
3+ [27,30].
Mycobacterial culture. The sputum samples were processed
according to standard procedures [18,31], inoculated on blood
agar, Lowenstein Jensen (LJ) (BD BBLTM; Franklin Lakes, NJ,
USA) slants incubated for up to eight weeks and in Mycobacterium
Growth Indicator Tube (BD BBL MGIT960, Franklin Lakes, NJ,
USA) incubated for six weeks as described [22,23]. The criteria for
verification of isolates belonging to the MTC and the drug
resistance procedures were as described [5,18]. Note that the use
of blood agar was for contamination detection. Culture contam-
ination was considered if a DZM AFB negative sample grew on
blood agar (Table S2).
Drug susceptibility profile. The drug susceptibility profiles
were obtained from previously published data by the same author
for the relevant patients [22,23]. The susceptibility to four drugs
used as first line therapy namely; Streptomycine, Rifampicine,
Isoniazid and Ethambutol of DZM false negative cases were
identified and used for the public health component of this study.
Data management and analysis
Information obtained from the questionnaires, HIV status from
individual health record and corresponding TB results for each
patient were entered in Excel 2007. The data were then exported
to Stata (Stata ver. 11/SE for Windows, Stata Corp, College
station) and R software version 2.15.3 (http://cran.r-project.org/)
for appropriate statistical analyses.
Estimation of diagnostic test characteristics and
agreement. Assessment of diagnostic characteristic was done
using the diagt command in Stata (Stata ver. 11/SE for windows,
Stata Corp, College station) considering DZM and DFM as the
tests to be evaluated and culture on LJ media as the reference test
(gold standard). The kappa measure of agreement between
diagnostic tests was also calculated.
Survival analysis of time to detection of bacilli on
MGIT960. Survival analysis was done using the survival package
in the R software environment, the same excel data set was
converted into a CSV file and imported into R for the survival
analysis. The time (T= 19 days) denotes the maximum time to
detection in this study, but the total time of observation was 6
weeks (42 days). Using the Surv function within the survival analysis
package an event was defined as becoming positive and time to
detection measured in days. Note that the censor time is set at
T= 19. Kaplan-Meier graphs were generated for each explanatory
Table 2. Diagnostic performance of DZM&DFM against culture on LJ (gold standard) in detection of bacilli in clinical samples
obtained from patients at Mubende referral hospital, Uganda.
Evaluated test Gold standard
DZM/DFM* DZM/LJ DFM/LJ
Positive Negative Positive Negative Positive Negative
Positive 25 7 24 8 53 8
Negative 36 276 42 270 13 270
Estimate (95%CI) Estimate (95%CI)
Sensitivity (%) 36.4(24.9–49.1) 80.3(68.7–89.1)
Specificity (%) 97.1(94.4–98.7) 97.1((94.4–98.7)
Positive predictive value (%) 75.1(56.6–88.5) 86.9(75.8–94.2)
Negative predictive value (%) 86.5(82.2–90.1) 95.4(92.3–97.5)
Kappa agreement measure (%) 41.6(36.6–46.6) 79.7(74.3–85.1)
*DFM is used as the gold standard with DZM. Note that the rest of the comparison is done with Results on LJ media as the gold standard. The status (+/2) of the
reference tool will be the column status while the test tool is the row. For example (DZM/DFM) = row (+/2)/col(+/2).
doi:10.1371/journal.pone.0100720.t002
Table 3. Shows factors associated with DZM false negative results.
Variable Level Odds ratio (95% CI) p-value
HIV status Negative – –
Positive 6.53(2.29–18.58) 0.00
Unknown 0.38(0.12–1.21) 0.10
Tobacco usage Non smokers – –
Smokers 2.32(1.07–5.01) 0.03
Sample type Sputum – –
Lymph node aspirate 0.52(0.22–1.26) 0.15
Abscess aspirate 6.32(1.87–21.33) ,0.01
AUC= 0.84.
doi:10.1371/journal.pone.0100720.t003
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variable in the descriptive survival analysis. A Cox proportion
hazard model was built from explanatory factors that showed
significant variation in time to detection and fulfilled the model
assumptions. The post model evaluation was done using standard
procedures.
Diagnostic/screening algorithm. The diagnostic/screen-
ing algorithm in this study is a layout of a logistic regression model
that contains some of the WHO recommended predictors [3,28].
The analysis in this study explored the model (algorithm) case
prediction in each of the sub-populations formed by the different
combinations of clinical and diagnostic aspects so as to give an
estimate of the likely-hood of case detection. In order to estimate
the utility (predictive ability) of this diagnostic algorithm, features
of the clinical history and DZM results were used as predictors of
true disease status (culture on LJ results) in a multivariable logistic
regression model. The model was built in a forward step-by-step
approach that resembles the events leading to a physician
requesting for DZM test in Mubende referral hospital. At each
step the proportions of true cases and predicted cases (Probability
of being a case) are calculated and presented in an algorithm tree/
chart. Logit(pTB)= b0+bX1+ b2X2+ b3X3….
Where pTB is the predicted probability of being TB positive on
LJ media, x1, x2 and x3 are the predictors in the model while b0 is
the intercept term and b1, b 2 and b3 are regression coefficients.
All the predictor variables included in the final model gave at
least P= 0.25 in the univariable logistic regression. In order to
maximize the number of true cases classified when DZM is used in
this algorithm, a receiver operating characteristic curves (ROC)
analysis was done to identify the lowest probability cut-off with the
highest sensitivity and specificity. The final model validation and
post estimation analysis were done using the standard statistical
methods in Stata.
Results
344 individuals were examined, 206 (60%) were male and 138
(40%) were female, with an average age of 31.5 (18.5–44.3) years,
height of 155.7 (153.8–157.4) cm and weight of 50.4 (49.2–51.55)
kg. Forty-seven percent of the patients were married and 41%
single, the rest widowed, divorced or too young to be categorized.
Summary of DZM, DFM and culture results
The descriptive results of DZM, DFM and culture are given in
Table 1. Acid-fast bodies (AFB) were identified 32 (9.3%) samples
from 344 patients examined by DZM at the Mubende regional
referral hospital. Samples from 61 patients (18%) had AFB on
DFM, and growth on LJ media detected 66 cases (19%) (Table 1).
Most of the cases detected by DZM had a bacillary load of +3.
Of the DZM positive patients, 19 (59.3%) and 13 (40.6%) were
male and female respectively. The same trend is reflected
throughout the test on the rest of the diagnostic tools. A majority
of the DZM positive samples were recovered from HIV infected
middle-aged patients. A prospective follow-up of the specimen
analysis from DZM through DFM and then culture showed a
steady increase in the number of positive cases detected (Table 1).
It is noteworthy that the culture contamination proportion was 6/
344 or approximately 2% of the cultured samples showed culture
contamination (Table S2).
Diagnostic features and comparison of tests
DZM was able to detect 36.4% of the true TB cases in this
study. This test had a sensitivity and specificity of 36.4% (95%
CI= 24.9–49.1) and 97.1% (95% CI=94.4–98.7) when compared
to the gold standard respectively. The comparison with DFM as
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the gold standard against DZM showed that DZM picked up 25 of
61 cases positive on DFM. The low sensitivity of DZM was also
reflected in the low kappa agreement measure against the gold
standard. It is noteworthy that there was no significant difference
in false positives recovered when DZM was compared to the gold
standard (Table 2).
DFM detected 53 of the 66 cases detected by the gold standard
and therefore had a sensitivity and a specificity of 80.3% (95%
CI= 68.7–89.1) and 97.1% (95% CI=94.4–98.7) respectively.
Figure 2. Kaplan-Meier plots showing the Time to detection (TTD) of bacilli on MGIT960 (Y-axis = s(t) which is the survival function,
X-axis is the TTD in days). Top row first graph shows the time to detection of all the 344 patients without any covariate structure considered.
Second, third and fourth show the TTD when HIV status, Smoking and alcohol consumption are considered as covariates respectively. Bottom row:
The first, second, third and fourth graph show the TTD for the combination of (patients who consume alcohol and smoke), (patients who smoke,
consume alcohol and are HIV positive), (HIV negative patients who neither consume alcohol nor smoke) and bacillary load levels respectively.
doi:10.1371/journal.pone.0100720.g002
Table 5. Cox proportional hazard model of the time to detection of M. tuberculosis bacilli on MGIT960 based on 344 patients at the
Mubende referral hospital.
Variable Level Coefficients (95% CI) Hazard Ratio (95% CI) p-value
HIV status Negative – –
Positive 2.94 (1.54–5.59) 18.9 (4.66–267) 0.001
Unknown 0.27 (0.11–0.59) 1.31 (1.12–1.80) 0.001
Tobacco usage Non smokers – –
Smokers 1.94 (1.19–3.17) 6.96 (3.29–23.8) 0.007
Alcohol usage Non consumers – –
Consumers 1.88 (1.10–3.20) 6.55 (3.00–24.5) 0.019
doi:10.1371/journal.pone.0100720.t005
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This too is reflected in the high kappa agreement measure against
the gold standard. Consequently, DFM produced a higher positive
and negative predictive value than DZM (Table 2). It should be
noted that although MGIT 960 recovered more positive cases
(n = 69) than culture on LJ media (n = 66) (Table S2), given that
these two agreed on 60 cases, the latter was considered as the gold
standard for this study.
DZM-false negative cases
A significant proportion of HIV positive cases gave false
negative results on DZM. In fact the odds of false negative results
among HIV positive patients were six times those of HIV negative
patients (Table 3). Smoking also appears to be associated with false
negative result, this is because the odds of false negative DZM
results among smokers were twice those of non-smokers. Similarly,
sample type (clinical presentation) was also associated with false
negative results i.e. the odds of an abscess aspirate giving a false
negative results was almost six times that of a sputum sample
(Table 3). The drug susceptibility profiles of DZM false negative
cases showed that eight cases were resistant to at least one drug
used in the first line treatment against TB in Mubende district
(Table 4). Of these one was resistant to both Rifampicin and
Isoniazid, hence classified as multidrug resistant (MDR).
Evaluation of time to detection on MGIT960
The time to detection, (TTD) of bacilli on MGIT 960 is
presented in Figure 2 and the hazard ratios are given in table 5. In
general, the majority of patients’ time to detections was 2–4 days,
but the maximum time to detection was 19 days. From the
Kaplan-Meier plots the time to detection on MGIT960 appears to
be a function of bacillary load in a specimen (Figure 2). The Cox
proportional hazard model shows that the hazard of becoming a
Figure 3. The diagnostic algorithm chart showing the case proportions formed by clinical and diagnostic combinations with data
from Mubende regional referral hospital, AUC is the area under the curve, PP=predicted probability of being TB case, TS= total
number of true TB cases in each covariate pattern based on the gold standard, N= the total number of individual in a specific
covariate pattern (sub-population formed by combining clinical factors), TCC= total number of TB-cases accurately classified my
the model. The adjusted case predictions are made at a probability cut off P = 0.199 as established in figure 3, the broken lines shows pathways that
are most likely to increase numbers of false positive cases.
doi:10.1371/journal.pone.0100720.g003
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positive culture on MGIT960 conditional on the patient present-
ing with a cough persistent for at least two weeks and/or
lymphadenitis/an abscess is ,19 times higher if the patient is also
HIV positive and,7 times higher if they are a smoker or consume
alcohol (Table 5).
Diagnostic/screening algorithm
A patient from whom sputum and/or a lymph node or abscess
aspirate was taken must have presented with a cough that had
persisted for at least two weeks and/or lymphadenitis or an
abscess. This clinical facet alone contained 38, 18 and 9 true TB
cases proportion-wise respectively. However if this were to be used
alone as predictor in this algorithm (Model), the model would not
be able to classify any cases regardless of the high AUC (Figure 3).
(The author has chosen to follow HIV positive smokers for the
purposes of explaining). When this clinical picture was combined
with the patient’s tobacco smoking status, the number of true TB
cases among smokers was 19, 8 and 6 respectively. At this step the
model would be able to accurately classify 6 of the 66 true cases
with AUC=0.66. If the HIV status of these patients was then
added to the model, the total number true cases among HIV
positive smokers were 11, 5, and 3 respectively. At this step the
model could accurately classify 22 of the 66 true cases. At this
point if the physician asked the patient to take a DZM test, the
number of true cases among DZM positive, HIV positive smokers
was 5, 3 and 1 respectively. At this point the model could
accurately classify 33 of the 66 true cases with AUC=0.88. The
optimized probability cut-off with the highest sensitivity and
specificity is present in (Figure 4). After adjusting the cut-off
probability the model with the same AUC=0.88 could classify 52
of the 66 true TB cases (Table 6 and Figure 3). This however
increased the number of false positive cases up to 50. The
pathways that are most likely to bring in false positive cases are
highlighted as broken lines (Figure 3).
Discussion
Direct smear microscopy (DZM) is the principal method of TB
diagnosis in resource-limited settings like Mubende district,
Uganda [3,6,32]. This is because it is a cheap procedure that
can deliver results in less than a day [32]. There is a common
agreement on the limitation of this test, some of which include a
low sensitivity, especially on specimens with a low bacillary load
[7,8,13]. The findings in this study are in agreement with these
previous reported on DZM characteristics. For example the
findings show that the greatest proportion of high bacillary load
samples (+3) were identified on DZM. This means that of those
that sought health care under the set criterion, DZM would most
likely pick up the highly symptomatic active TB patients [21]. On
the other hand, although not statistically significant, more of the
low bacillary load samples (+1 and +2) were recovered by tools not
used at this facility (DFM and culture).
One of the positive attributes of DZM is that it has a high
specificity, and in this study a specificity of 97.1% was observed.
Therefore it adequately classifies true negative cases, leaving little
room for wastage of scarce resources on inappropriate treatment
[32]. This limited frequency of false-positive results by DZM
normally outweighs the advantages of high detection rates in
mycobacterial culture considering the importance of timely
diagnosis with regards to TB in resource-limited settings [5]
[27]. This would not necessarily be the case for DFM [5]. On the
other hand, the low kappa agreement between DZM and culture
on LJ media highlights the significantly high possibility of missing
Figure 4. The receiver operating characteristics curve (ROC) showing the lowest cut-off probability with the highest specificity and
sensitivity for the diagnostic/screening algorithm, this probability is used to adjust the case classification in figure 2. The Solid line
represents DZM on its own at AUC=,66%, the dotted line shows the model with DZM and the three predictors at AUC=, 88%.
doi:10.1371/journal.pone.0100720.g004
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of TB cases thus a low sensitivity. In this regard, DZM alone was
able to correctly classify only 24 of the 66 true cases, so in the
absence of a rigorous screening procedure nearly two thirds of the
cases had a possibility of being missed. Studies have in the recent
past documented the phenomenon of smear-negative TB cases
[10,13,19,33] especially among HIV infected patients. This
phenomenon was also explored in this study using a logistic
regression model to determine associated factors. The findings
reveal that an HIV positive patient was more likely to give a false
negative result on DZM than an HIV negative patient. The
finding supports Corbett’s conclusion that HIV was largely
associated with the increased burden of undiagnosed TB in
Zimbabwe [21]. This status quo would be counterproductive to
the current tuberculosis control program in Uganda, as it
contributes to further spread of the disease [32]. The sample
type, which was a proxy for either the patient’s pulmonary or
extra-pulmonary tuberculosis status was also associated with DZM
false negative results. In other words, a sample from the extra-
pulmonary compartment specifically from an abscess was more
likely to produce a false negative result on DZM. Although the
direct link between extra-pulmonary tuberculosis and false
negative results is not well documented, studies have shown that
these two phenomena are associated with HIV infection [34,35]. It
should however be note that the observed association in this study
is based on a small proportion of patients with abscesses, so a
larger number is needed to validate the association. Smokers were
on the other hand more likely to give DZM false negative result
than non-smokers. Although this finding is in agreement with
previous studies [36], other reports have documented it as delayed
AFB conversion within smokers [37]. Analysis of drug suscepti-
bility profiles of the DZM false negative cases shows that some of
these were infected with M. tuberculosis bacilli which were resistant
to at least one of the four drugs used as first line treatment for
tuberculosis, one of them was categorized as case multi drug
resistant (MDR) tuberculosis. This finding has public health
implications, because among the would-be under-diagnosed group
was an individual who had the potential of spreading MDR-TB to
the public.
The comparison of DFM with the gold standard reveals that it
has much better diagnostic characteristics than DZM, with an
over 50% increment in case detection. This is in agreement with
reports in Kenya [38] and India [39], although the later
documented a 26% increment. On the other hand Toman’s
[27] only reported a slight difference in sensitivity between the two
methods but his conclusions on false positive cases between the
two tools is in agreement with the current study. The higher
agreement of DFM and culture on LJ media also means that more
patients could get results and start treatment much faster if DFM
had been used in this setting. Therefore although it would require
financial and skills input, an upgrade from DZM to DFM would
significantly improve the case detection especially of smear
negative HIV positive TB cases at Mubende regional referral
hospital. This has also been recommended elsewhere [10,13,38].
In reality, this diagnostic test was only carried out on a duplicate
sample transported to the Mycobacteriology Laboratory, Depart-
ment of Medical Microbiology, Makerere University located in
Uganda’s capital city. Although DFM has been rolled out in some
referral hospitals in last one year, in general it is still not widely
used in health facilities in rural areas. The greatest challenge to
using DFM in resource poor settings is the fact that such areas are
underfunded, with over-worked personnel who receive a huge bulk
of diagnostic specimens every day [11,12]. Therefore, unless this is
addressed, the diagnostic benefits of DFM could be missed if andT
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when rolled out because the quality of the smear declines with time
[27].
It would be idealistic to expect that all resource-limited settings
are able to roll out programmes to use DFM in all diagnostic
centres given the extra cost associated with it. For those facilities
that would not immediately adopt it, the utility of a diagnostic
algorithm/screening procedure with and without DZM in it was
explored in this study.
WHO recommends several diagnostic algorithms for different
case scenarios, however, the 2006/7 international standards for
tuberculosis care is the most used [28]. The use of the clinical
history like HIV status and symptoms can greatly increase the
probability of detecting TB cases [40], although cases are bound to
be missed if these are used in isolation [21]. The findings
demonstrate that if the clinical presentation of; either cough,
lymphadenitis or abscess alone was used to predict TB status, no
cases would be accurately classified in this algorithm. However, a
cough persistent for at least two weeks on its own has been
reported to have a sensitivity of 55% among people living with
HIV [8]. On the other hand in Ethiopia, it has been documented
that if this type of cough were considered alone one could miss up
to 56% of the cases [41]. In the current study when the first clinical
presentation was combined with the patients tobacco smoking
status the algorithm could accurately classify six TB cases, in effect
six cases identified by this model are attributable to knowing the
patients smoking status. Access to the patient’s HIV status
accurately classifies another sixteen cases. To put this in context
at this point the screening algorithm could accurately classify two
cases less of what DZM could when used on its own. The TB
diagnostic utility of the HIV status has been reported in the recent
past [8,21,29,42] and although there is a common recognition that
HIV screening of all suspected TB cases would greatly improve
case detection, it can only be adopted when simple and cheap HIV
diagnostics are available in these settings [1,21]. Adding the DZM
results to this screening algorithm would accurately classify 33 of
the 66 true TB cases, that is to say the model gives DZM a 13.6%
(9/66) increment in case classification. The number of true cases
classified was maximized to 52/66 (42% increment in case
classification) by taking a specificity trade-off that inherently comes
with DZM. Although this adjusted screening algorithm would
improve case classification, the choice of such a screening
algorithm over adopting DFM would come with a problem of
over-diagnosing. This optimisation produced up to 50 false
positive cases. According to estimates produced [43] on TB
control in rural Uganda, if such a choice was taken in Mubende
district, it could have potentially cost the control programme up to
(506351=£17,550) in inappropriate TB management during the
study period. However, the screening chart highlights the
pathways that are most likely to produce these false positive cases.
It is noteworthy that although the same analysis was not done with
DFM as the test of choice, its diagnostics characteristics in this
algorithm can be inferred from the current analysis. For example:
From this analysis the gold standard gives a point of reference with
regards to disease status (n = 66), therefore the three clinical
predictors together with DZM give us a measure of how close we
can get to detecting these 66 cases. With this in mind, if DFM
alone detects 53 of the 66 cases and DZM and DFM have the
same false positive rate, it was inferred that DFM would detect
significantly more cases when used with the three predictors. The
adjusted cut-off probability would however be different in this
case. The clinical implication of this is that it is possible to arrive at
an accurate diagnosis of TB with this screening algorithm using a
single sample hence early treatment commencement.
Establishing bacillary load is a crucial but laborious process,
which in some cases could result in ocular complications in over-
worked laboratory technicians in high TB density areas [11,12].
Therefore exploring diagnostic tool combinations that can reduce
the workload is also a crucial factor in the TB control strategy.
Analysis of MGIT 960 results reveals an association between time
to detection and bacillary load of samples, in other words the
higher the bacillary load the shorter the time to detection. This is
in concordance with previous reports [17]. The use of clinical
features as proxies for bacillary load shows that time to detection of
bacilli was significantly associated to the following; HIV status,
cigarette smoking and alcohol consumption. It might be possible to
combine the clinical picture and time to detection to make
inferences about bacillary load, which then eliminates the extra
work put into microscopic bacillary quantification. Therefore if
and when MGIT960 is introduced it is worthwhile exploring the
possibility of using this technique so as to reduce the strain put on
laboratory technicians in establishing bacillary load.
The limitation to this study were; 1) the number of patients used
was lower than other studies that have compared diagnostics in
resource limited settings. The sample size used however gave
enough statistical power to detect differences. 2) a single sample per
patient was used for the analysis. The WHO algorithms prescribe
the use of three samples of sputum in classifying certain disease
status. However, given that this was a cross sectional research study,
the findings should be viewed as a cross sectional representation of
the dynamics in this areas, although can be a reflection of what is
happening in other resource limited settings with the same
characteristics. Note that, all sputum sample collected were
collected at times prescribed by WHO. Therefore the interpreta-
tions drawn from this work should take these issues in consideration.
The utility of a diagnostic test/tool/algorithm usually depends
on the disease incidence in the population, the sensitivity and
specificity of the test, tool and or algorithm, the physical risk and
the associated cost implications. In this regard clinical symptoms
are not any different from diagnostic tests with the exception of
subjectivity. The challenge in clinical settings is establishing the
optimum predictors (clinical questions) since the factors that
govern diagnostic tools vary in populations of different geograph-
ical locale. Therefore findings in this study suggest that availing
resources for screening TB suspects for HIV might be the only
limiting factor in adopting such screening algorithms in resource
limited settings.
Conclusion
The study supports the concern that using DZM alone risks
missing majority of TB cases, in this case we found nearly 60%, of
who one was an MDR case. Although adopting DFM would
reduce this proportion to 19%, the use of a three-predictor
screening algorithm together with DZM was almost as good as
DFM alone. It’s utility is whoever subject to HIV screening all TB
suspects.
Supporting Information
Table S1 Questionnaire: The epidemiology of tubercu-
lous and non-tuberculous mycobacteria in Mubende
district, Uganda.
(PDF)
Table S2 Database: A comparison of TB diagnostic
tools used on samples from Mubende regional referral
hospital.
(XLSX)
Screening Algorithm for Tuberculosis in Resource Limited Settings
PLOS ONE | www.plosone.org 11 June 2014 | Volume 9 | Issue 6 | e100720
Acknowledgments
The authors are grateful to the participant who contributed to all of the
studies and the teams of investigators involved. These include Dr. Fred
Miti, Dr, Kenneth Batsikana, Sr. Thereza Kitandwe, Ms Sylvia
Nabukeera, Ms Stella Mumbi, Mr. Muhindo Emmanuel. We are also
grateful to the Dr. Wilson Mubiru the director of district health services
and Dr. Edward Nkurunziza the medical superintendent of Mubende
regional referral hospital and Dr. Martin Zziwa for all the support offered
during the study. Special thanks go Dr. Ian Handel for the contribution to
data analysis, Dr. Tone. B. Johansen, Dr. Djonne Berit and Ms. Vigdis
Edvardsen for the laboratory work at the National Veterinary Institute.
Author Contributions
Conceived and designed the experiments: AM ES. Performed the
experiments: AM SM WS DB. Analyzed the data: AM BB ES DB.
Contributed reagents/materials/analysis tools: AM BB ES WS SM.
Contributed to the writing of the manuscript: AM BB ES WS SM DB.
References
1. WHO (2013) Global tuberculosis report 2013. Geneva: World health
Organisation. 1–3.
2. Reichman L (2012)The global epidemic of multidrug-resistant TB, giving the sir
john crofton memorial lecture on ‘‘Timebomb’’ revisited ten years later: Can we
sustain progress or are we losing the war?; Kuala Lumpur. International journal
of lung and tubercle disease.
3. WHO (1997) Global tuberculosis programme, treatment of tuberculosis:
Guidelines for national programmes. Geneva: World health Organisation. 220.
4. Globalgiving (2010) Advocacy for 8000 TB affected persons in Mubende. United
Kingdom: Globalgivining.
5. WHO (2011) Policy statement on fluorescence light emitting diode microscopy
for diagnosis of tuberculosis. Geneva: World Health Organisation
6. Union TDI (2005) Tuberculosis bacteriology-priorities and indications in high
prevalence countries: Position of the technical staff of the tuberculosis division of
the international union against tuberculosis and lung disease counterpoint. The
International Journal of Tuberculosis and Lung Disease 9: 355–361.
7. David H (1976) Bacteriology of the mycobacterioses. U S Dept of Health,
Education, and Welfare, Public Health Service, Center for Disease Control,
Bureau of Laboratories, Bacteriology Division, Mycobacteriology Branch
8. Reid MJA, Shah NS (2009) Approaches to tuberculosis screening and diagnosis
in people with HIV in resource-limited settings. The Lancet Infectious Diseases
9: 173–184.
9. Steingart KR, Ng V, Henry M, Hopewell PC, Ramsay A, et al. (2006) Sputum
processing methods to improve the sensitivity of smear microscopy for
tuberculosis: a systematic review. The Lancet Infectious Diseases 6: 664–674.
10. Harries AD, Maher D, Nunn P (1998) An approach to the problems of
diagnosing and treating adult smear-negative pulmonary tuberculosis in high-
HIV-prevalence settings in sub-saharan Africa. Bulletin of World Health
Organization 76: 651–662.
11. Foulds J, O’Brien R (1998) New tools for the diagnosis of tuberculosis: the
perspective of developing countries. The International Journal of Tuberculosis
and Lung Disease 2: 778–783.
12. De Cock KM, Wilkinson D (1995) Tuberculosis control in resource-poor
countries: alternative approaches in the era of HIV. The Lancet 346: 675–677.
13. Steingart KR, Henry M, Ng V, Hopewell PC, Ramsay A, et al. (2006)
Fluorescence versus conventional sputum smear microscopy for tuberculosis: a
systematic review. The Lancet Infectious Diseases 6: 570–581.
14. Marais BJ, Brittle W, Painczyk K, Hesseling AC, Beyers N, et al. (2008) Use of
Light-Emitting Diode Fluorescence Microscopy to Detect Acid-Fast Bacilli in
Sputum. Clinical Infectious Diseases 47: 203–207.
15. Burman WJ, Stone BL, Reves RR, Wilson ML, Yang Z, et al. (1997) The
incidence of false-positive cultures for Mycobacterium tuberculosis. American
Journal of Respiratory and Critical Care Medicine 155: 321–326.
16. Bemer P, Palicova F, Ru¨sch-Gerdes S, Drugeon HB, Pfyffer GE (2002)
Multicenter Evaluation of Fully Automated BACTEC Mycobacteria Growth
Indicator Tube 960 System for Susceptibility Testing of Mycobacterium
tuberculosis. Journal of Clinical Microbiology 40: 150–154.
17. Chihota VN, Grant AD, Fielding K, Ndibongo B, van Zyl A, et al. (2010) Liquid
vs. solid culture for tuberculosis: performance and cost in a resource-constrained
setting. The International Journal of Tuberculosis and Lung Disease 14: 1024–
1031.
18. Siddiqui S (2007) Mycobacteria growth indicator tube (MGIT) culture and drug
susceptibility demonstration projects. In: FIND, editor. FIND. Switzerland
19. Huerga H, Varaine F, Okwaro E, Bastard M, Ardizzoni E, et al. (2012)
Performance of the 2007 WHO Algorithm to Diagnose Smear-Negative
Pulmonary Tuberculosis in a HIV Prevalent Setting. PLoS ONE 7: e51336.
20. Ratzinger F, Bruckschwaiger H, Wischenbart M, Parschalk B, Fernandez-Reyes
D, et al. (2012) Rapid Diagnostic Algorithms as a Screening Tool for
Tuberculosis: An Assessor Blinded Cross-Sectional Study. PLoS ONE 7:
e49658.
21. Corbett EZ, Cheung YB, Bandason T, Dauya E, Munyati SS, et al. (2010)
Provider-initiated symptom screening for tuberculosis in Zimbabwe: diagnostic
value and the effect of HIV status. Bulletin of World Health Organization 88:
13–21.
22. Muwonge A, Kankya C, Olea-Popelka F, Biffa D, Ssengooba W, et al. (2013)
Molecular investigation of multiple strain infections in patients with tuberculosis
in Mubende district, Uganda. Infection, Genetics and Evolution 17: 16–22.
23. Muwonge A, Malama S, Johansen TB, Kankya C, Biffa D, et al. (2013)
Molecular Epidemiology, Drug Susceptibility and Economic Aspects of
Tuberculosis in Mubende District, Uganda. PLoS ONE 8: e64745.
24. Rwabwogo M (2007) Uganda district information handbook; Rwabwogo M,
editor. Kampala: Fountain publishers.
25. Piot M (1967) A simulation model of case finding and treatmnent in tuberculosis
control programmes. Geneva: World health organisation.
26. Kankya C, Mugisha A, Muwonge A, Skjerve E, Kyomugisha E, et al. (2011)
Myths, perceptions knowledge, attitudes, and practices (KAP) linked to
mycobacterial infection management among the pastoralist communities of
Uganda. Adv Trop Med Pub Health Int 1: 111–124.
27. Toman K (2004) Case detection, treatment, and monitoring -questions and
answers. World Health Organization. 11–26.
28. WHO (2007) Improving the diagnosis and treatment of smear-negative
pulmonary and extrapulmonary tuberculosis among adults and adolescents
recommendations for HIV-prevalent and resource-constrained settings. Geneva:
World health Organisation. 379 p.
29. Wilkinson D, De cock KM, Sturm AW (1997) Diagnosing tuberculosis in a
resource-poor setting: the value of a trial of antibiotics. Trans R Soc Trop Med
Hyg 91: 422–424.
30. Toman K (2004) What are the advantages and disadvantages of fluoroscense
microscopy? In: K Toman, editor. In: Toman’s tuberculosis case detection,
treatment and monitoring- questions and answers. Geneva: World Health
Organisation. 31–34.
31. WHO (1998) Microscopy. In: Organisation WH, editor. Laboratory services in
TB control part II:. Geneva: World Health Organisation.
32. Walker D (2001) Economic analysis of tuberculosis diagnostic tests in disease
control: how can it be modelled and what additional information is needed? The
International Journal of Tuberculosis and Lung Disease 5: 1099–1108.
33. Swai H, Mugusi F, Mbwambo J (2011) Sputum smear negative pulmonary
tuberculosis: sensitivity and specificity of diagnostic algorithm. BMC Research
Notes 4: 475.
34. Whitehorn J, Ayles H, Godfrey-Faussett P (2010) Extra-pulmonary and smear-
negative forms of tuberculosis are associated with treatment delay and
hospitalisation. The International Journal of Tuberculosis and Lung Disease
14: 741–744.
35. Wilson D, Nachega J, Morroni C, Chaisson R, Maartens G (2006) Diagnosing
smear-negative tuberculosis using case definitions and treatment response in
HIV-infected adults. The International Journal of Tuberculosis and Lung
Disease 10: 31–38.
36. Laurence B, Madhukar P, Virginia D, Daphne IL, Laura L, et al. Tobacco
Smoking And Spectrum Of Tuberculosis Infection And Disease In South
African Patients With Suspected Tuberculosis. C53 Epidemiology of Latent and
Active Tuberculosis: American Thoracic Society. A4758–A4758.
37. Abal AT, Jayakrishnan B, Parwer S, El Shamy A, Abahussain E, et al. (2005)
Effect of cigarette smoking on sputum smear conversion in adults with active
pulmonary tuberculosis. Respiratory Medicine 99: 415–420.
38. Kivihya-Ndugga LEA, van Cleeff MRA, Githui WA, Nganga LW, Kibuga DK,
et al. (2003) A comprehensive comparison of Ziehl-Neelsen and fluorescence
microscopy for the diagnosis of tuberculosis in a resource-poor urban setting.
The International Journal of Tuberculosis and Lung Disease 7: 1163–1171.
39. Kumari A, Prasanthi K (2005) Efficacy of fluorochrome stain in the diagnosis of
pulmonary tuberculosis co-infected with HIV. 179–185.
40. Were W, Moore D, Ekwaru P, Mwima G, Bunnell R, et al. (2009) A simple
screening tool for active tuberculosis in HIV-infected adults receiving
antiretroviral treatment in Uganda. The International Journal of Tuberculosis
and Lung Disease 13: 47–53.
41. Shah SD, Lambert M, Ahmed L, Leulseged J, Kebede S, et al. (2009) Intensified
tuberculosis case finding among HIV-Infected persons from a voluntary
counseling and testing center in Addis Ababa, Ethiopia. J Acquir Immune
Defic Syndr 15: 537–545.
42. Samb B, Henzel D, Daley CL, Mugusi F, Niyongabo T, et al. (1997) Methods
for diagnosing tuberculosis among in-patients in Eastern Africa whose sputum
smears are negative. The International Journal of Tuberculosis and Lung
Disease 1: 25–30.
43. Saunderson PR (1995) An economic evaluation of alternative programme
designs for tuberculosis control in rural Uganda. Social Science & Medicine 40:
1203–1212.
Screening Algorithm for Tuberculosis in Resource Limited Settings
PLOS ONE | www.plosone.org 12 June 2014 | Volume 9 | Issue 6 | e100720
